How is the Cytosorbents Corp today?

The Cytosorbents Corp today is trading in the down by -1.18% at 0.84.

How has Cytosorbents Corp performed historically?

The Cytosorbents Corp is currently trading down -1.18% on an intraday basis in the past week the index fell 0.00%. The index has been down -26.96% in the past quarter and fell -10.64% in the past year. You can view this in the overview section.

What is Cytosorbents Corp Annual Revenue?

Cytosorbents Corp Annual Revenue rose 14.51%, in the last year to $35.59 M. Its sector's average revenue growth for the last fiscal year was 9.99%.

What is Cytosorbents Corp Annual Net Profit?

Cytosorbents Corp Annual Net Profit rose 29.16% in the last year to $20.72 M. Its sector's average net profit growth for the last fiscal year was 7.43%.

What is Cytosorbents Corp Price to Earning Ratio?

Cytosorbents Corp Price to Earning Ratio is -3.32, which is negative.

What is Cytosorbents Corp Stock Price?

Cytosorbents Corp Stock Price fell 10.64% and underperformed its sector by 17% in the past year.

What is Cytosorbents Corp Quarterly Revenue?

Cytosorbents Corp Quarterly Revenue fell 2.92% YoY to $8.73 M. Its sector's average revenue growth YoY for the quarter was 8.43%.

What is Cytosorbents Corp Quarterly Net profit?

Cytosorbents Corp Quarterly Net profit rose 75.72% YoY to $1.48 M. Its sector's average net profit growth YoY for the quarter was 53.07%.

What is Cytosorbents Corp Debt to Equity Ratio?

Cytosorbents Corp Debt to Equity Ratio of 2.42 is higher than 1. This implies that company assets are financed through debt.

What is Cytosorbents Corp Return on Equity(ROE)?

Cytosorbents Corp Return on Equity(ROE) for the last financial year was -119.8%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Cytosorbents Corp Mutual Fund Holding?

Cytosorbents Corp Mutual Fund Holding decreased by 1.56% in the last quarter to 11.81.

What is Cytosorbents Corp Promoter Share Holding?

Cytosorbents Corp Promoter Share Holding increased by 0.32% in the most recent quarter to 37.31%.

What is Cytosorbents Corp Interest Coverage Ratio?

Cytosorbents Corp Interest Coverage Ratio is -15.02, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Cytosorbents Corp Institutional Holding?

Cytosorbents Corp Institutional Holding increased by 2.2% in the last quarter to 27.12.

Cytosorbents Corp XNAS: CTSO

Cytosorbents Corp Live Share Price Today, Share Analysis and Chart

Name: Cytosorbents Corp: Is Infosys Ltd. worth buying?
Item: Cytosorbents Corp
Rating: 1.262527875
Author: Trendlyne DVM scores

Weak Stock

about

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber,...

0.84 -0.01 (-1.18%)

47.83% Fall from 52W High

52,325 XNAS Volume

XNAS 23 May, 2025 5:30 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

14.7 / 100

Technically Bearish

30.8 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 495%

3 analysts

Cytosorbents Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cytosorbents Corp Live Share Price Today, Share Analysis and Chart

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber,...

47.83% Fall from 52W High

SWOT Analysis

Cytosorbents Corp Live Price Chart

Cytosorbents Corp FAQ

How is Cytosorbents Corp today?

Cytosorbents Corp today is trading in the red, and is down by -1.18% at 0.84.

How has Cytosorbents Corp performed historically?

Cytosorbents Corp is currently trading down -1.18% on an intraday basis. In the past week the stock fell 0.00%. stock has been down -26.96% in the past quarter and fell -10.64% in the past year. You can view this in the overview section.